88 related articles for article (PubMed ID: 22569149)
21. Arterial concentration profiles of two blood pool agents and Gd-DOTA after intravenous injection in rabbits.
Corot CA; Violas X; Robert P; Port M
Acad Radiol; 2002 May; 9 Suppl 1():S137-9. PubMed ID: 12019850
[No Abstract] [Full Text] [Related]
22. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity.
Fossheim SL; Fahlvik AK; Klaveness J; Muller RN
Magn Reson Imaging; 1999 Jan; 17(1):83-9. PubMed ID: 9888401
[TBL] [Abstract][Full Text] [Related]
23. Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
Xiao Y; Xue R; You T; Li X; Pei F; Wang X; Lei H
Carbohydr Res; 2014 Aug; 395():9-14. PubMed ID: 24995911
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance imaging of the middle and inner ear after intratympanic injection of a gadolinium-containing gel.
Berglin CE; Laurell G; Bramer T; Edsman K; Counter SA; Klason T; Ekborn A
Otol Neurotol; 2014 Mar; 35(3):526-32. PubMed ID: 24270726
[TBL] [Abstract][Full Text] [Related]
25. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
[TBL] [Abstract][Full Text] [Related]
26. Intraarticular diffusion of Gd-DOTA after intravenous injection in the knee: MR imaging evaluation.
Drapé JL; Thelen P; Gay-Depassier P; Silbermann O; Benacerraf R
Radiology; 1993 Jul; 188(1):227-34. PubMed ID: 8511303
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging of the inner ear after both intratympanic and intravenous gadolinium injections.
Iida T; Teranishi M; Yoshida T; Otake H; Sone M; Kato M; Shimono M; Yamazaki M; Naganawa S; Nakashima T
Acta Otolaryngol; 2013 May; 133(5):434-8. PubMed ID: 23294239
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.
de Smet M; Heijman E; Langereis S; Hijnen NM; Grüll H
J Control Release; 2011 Feb; 150(1):102-10. PubMed ID: 21059375
[TBL] [Abstract][Full Text] [Related]
29. Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function.
Hoffer ME; Allen K; Kopke RD; Weisskopf P; Gottshall K; Wester D
Laryngoscope; 2001 Aug; 111(8):1343-57. PubMed ID: 11568567
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic study of gadolinium-DOTA in control and streptozocin diabetic rats.
Michel A; Bonnet PA; Fernandez JP; Chambon C; Doucet D
J Pharm Pharmacol; 1992 Nov; 44(11):902-6. PubMed ID: 1361534
[TBL] [Abstract][Full Text] [Related]
31. A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent.
Cron GO; Wallace JC; Stevens WD; Fortin T; Pappas BA; Wilkins RC; Kelcz F; Santyr GE
Magn Reson Imaging; 2005 Jun; 23(5):619-27. PubMed ID: 16051036
[TBL] [Abstract][Full Text] [Related]
32. [MRI of acute myocardial infarction with injection of Gd-DOTA (15 patients)].
Richoz B; Delcour C; Depelchin P; Lenaers A; Jacquemin C; Gusella P; Struyven J
Ann Radiol (Paris); 1990; 33(2):93-8. PubMed ID: 2221784
[TBL] [Abstract][Full Text] [Related]
33. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
[TBL] [Abstract][Full Text] [Related]
34. MR imaging of the knee in acute rheumatoid arthritis: synovial uptake of gadolinium-DOTA.
Björkengren AG; Geborek P; Rydholm U; Holtås S; Petterson H
AJR Am J Roentgenol; 1990 Aug; 155(2):329-32. PubMed ID: 2115261
[TBL] [Abstract][Full Text] [Related]
35. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
36. Gd-DOTA. Pharmacokinetics and tolerability after intravenous injection into healthy volunteers.
Le Mignon MM; Chambon C; Warrington S; Davies R; Bonnemain B
Invest Radiol; 1990 Aug; 25(8):933-7. PubMed ID: 2394577
[TBL] [Abstract][Full Text] [Related]
37. Gd-DOTA: characterization of a new paramagnetic complex.
Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT
Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763
[TBL] [Abstract][Full Text] [Related]
38. Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
Lemasson B; Serduc R; Maisin C; Bouchet A; Coquery N; Robert P; Le Duc G; Troprès I; Rémy C; Barbier EL
Radiology; 2010 Nov; 257(2):342-52. PubMed ID: 20829544
[TBL] [Abstract][Full Text] [Related]
39. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
Fretellier N; Salhi M; Schroeder J; Siegmund H; Chevalier T; Bruneval P; Jestin-Mayer G; Delaloge F; Factor C; Mayer JF; Fabicki JM; Robic C; Bonnemain B; Idée JM; Corot C
Eur J Pharm Sci; 2015 May; 72():46-56. PubMed ID: 25736527
[TBL] [Abstract][Full Text] [Related]
40. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging.
Kamaly N; Kalber T; Ahmad A; Oliver MH; So PW; Herlihy AH; Bell JD; Jorgensen MR; Miller AD
Bioconjug Chem; 2008 Jan; 19(1):118-29. PubMed ID: 17985841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
